Clinical trial

Clinical and Histopathologic Characteristics of BAP1 Mutations

NCT01773655

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2013-01-01

PhaseN/A

Study timeline

Study start (unknown)2013-01-01Date precision: month

Registry last updated2020-07-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Malignant Pleural Mesothelioma (MPM)unresolved

Choroidal Nevusunresolved

Primary Uveal Melanoma (UM)unresolved

Metastatic Uveal Melanoma (UM)unresolved

Renal Cell Carcinomaunresolved

Cholangiocarcinomaunresolved

Interventions

tumor specimensOTHER

Sponsors & collaborators

Memorial Sloan Kettering Cancer Centerlead sponsor

United States Department of Defensecollaborator

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01773655 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.